Abstract
Background
Hepatic encephalopathy (HE) is a frequent complication of cirrhosis and a major public health problem. The incidence is increasing because of improved cirrhosis prognosis. The most widely used scale used to evaluate HE is the West-Haven (WH) scale, with scores ranging from 0 to 4. This scale is easy to use but not suitable for patients with altered consciousness and is not well known by physicians other than hepatologists who manage these conditions. For deep coma, the validated Glasgow Coma Scale (GCS) has been proposed. A new scale for comatose patients, the Full Outline of UnResponsiveness (FOUR) score, has recently been proposed and widely validated. The scale covers eye and motor responses, brainstem reflexes and breathing patterns and is the most validated coma scale.
Objective
To assess the diagnostic value of the FOUR score for detecting overt HE (OHE) in cirrhotic patients.
Methods
We prospectively included all patients admitted for cirrhosis at La Pitié-Salpêtrière Hospital from June 2012 to March 2014. Neurological status was assessed by a senior neurologic intensive care physician in the 24 first hours of ICU admission. The recently described and validated French version of the FOUR score was used.
Results
We screened 100 cirrhotic patients and included 94 (70 males [75 %], mean age 57 ± 11 years): 29 (31 %) with OHE (WH grades 2–4) and 65 (69 %) with No-OHE (WH grades 0–1). Mean FOUR and GCS scores were lower for OHE than No-OHE patients (p < 0.0001). The FOUR score could distinguish between WH grades 0–1, 2–3 and 4 (p < 0.0001). Furthermore, it could accurately detect and quantify OHE with an area under the c-index of 0.88 ± 0.10. The FOUR score was associated with outcome.
Conclusion
The FOUR score can be used to detect and quantify HE in cirrhotic patients, especially by non-hepatologists who are not familiar with the WH scale.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatol (Baltim MD). 2002;35(3):716–21.
Blei AT, Córdoba J. Practice Parameters Committee of the American College of Gastroenterology. Hepatic Encephalopathy Am J Gastroenterol. 2001;96(7):1968–76.
Córdoba J. New assessment of hepatic encephalopathy. J Hepatol. 2011;54(5):1030–40.
Wijdicks EFM, Bamlet WR, Maramattom BV, Manno EM, McClelland RL. Validation of a new coma scale: The FOUR score. Ann Neurol. 2005;58(4):585–93.
Weiss N, Mutlu G, Essardy F, Nacabal C, Sauves C, Bally C, et al. The French version of the FOUR score: A new coma score. Rev Neurol (Paris). 2009;165(10):796–802.
Kamath PS, Kim WR. Advanced liver disease study group. The model for end-stage liver disease (MELD). Hepatol (Baltim MD). 2007;45(3):797–805.
Iyer VN, Mandrekar JN, Danielson RD, Zubkov AY, Elmer JL, Wijdicks EFM. Validity of the FOUR score coma scale in the medical intensive care unit. Mayo Clin Proc Mayo Clin. 2009;84(8):694–701.
Wijdicks EFM, Rabinstein AA, Bamlet WR, Mandrekar JN. FOUR score and Glasgow coma scale in predicting outcome of comatose patients: a pooled analysis. Neurology. 2011;77(1):84–5.
Gundling F, Zelihic E, Seidl H, Haller B, Umgelter A, Schepp W, et al. How to diagnose hepatic encephalopathy in the emergency department. Ann Hepatol. 2013;12(1):108–14.
Author information
Authors and Affiliations
Corresponding author
Additional information
For the Brain-Liver Pitié-Salpêtrière Study Group (BLIPS).
Rights and permissions
About this article
Cite this article
Mouri, S., Tripon, S., Rudler, M. et al. FOUR Score, a Reliable Score for Assessing Overt Hepatic Encephalopathy in Cirrhotic Patients. Neurocrit Care 22, 251–257 (2015). https://doi.org/10.1007/s12028-014-0078-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-014-0078-5